Skip navigation
J&J

J&J to Get New Trial After $417 Million Verdict in Talc Case

J&J suffered a string of recent defeats in lawsuits alleging the company knew its talc-based products could cause various types of cancers and put profits over people’s health.

Johnson & Johnson deserves a new trial after a jury ordered the world’s largest maker of health-care products to pay $417 million to a woman who blamed the company’s iconic Baby Powder for causing her cancer, an appeals court concluded.

While there was sufficient evidence to uphold the jury’s finding that J&J improperly failed to warn Eva Echeverria about the health risks of talc-based powder, conflicting evidence about the product’s cancer links warrants another trial, the Los Angeles-based court said Tuesday.

The ruling is good news for J&J, which suffered a string of recent defeats in lawsuits alleging the company knew its talc-based products could cause various types of cancers and put profits over people’s health.

Last month, a California jury ordered J&J and Colgate-Palmolive Co. to pay about $10 million to a dying woman who said asbestos in their talc products caused her cancer. In May, a New York jury ordered J&J to pay $325 million to another woman who blamed her asbestos-related cancer on baby powder use.

By Jef Feeley and Edvard Pettersson

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish